UniQure Inc., a gene therapy biotech firm, plans a public offering to fund future research without specifying the amount.

UniQure Inc., a biotech company, has announced plans for a proposed public offering to raise capital for future research and development projects. The company, known for its work in gene therapy, aims to use the funds to advance its pipeline of treatments for rare diseases. Further details about the offering, such as the amount to be raised, have not been disclosed yet.

3 months ago
5 Articles